NIOX Group (LON:NIOX) Releases Quarterly Earnings Results

NIOX Group (LON:NIOX) announced its earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Trading Down 0.3%

LON NIOX opened at GBX 68.80 on Thursday. The stock has a market capitalization of £289.54 million, a P/E ratio of 41.95 and a beta of 0.92. The business has a 50 day simple moving average of GBX 65.69 and a 200 day simple moving average of GBX 61.63. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. NIOX Group has a one year low of GBX 53.84 and a one year high of GBX 76.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.